Mechanism by which quinapril improves vascular function in coronary artery disease

American Journal of Cardiology

Volumn 83, Issue 3, 1999, Pages 327-331

  Koh, Kwang Kon ^a   Bui, Minh N ^a   Hathaway, Londa ^a   Csako, Gyorgy ^b   Waclawiw, Myron A ^a   Panza, Julio A ^a   Cannon III, Richard O ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NITRATE; NITRIC OXIDE; NITRITE; QUINAPRIL; TRIACYLGLYCEROL;

ARTERY DIAMETER; ARTERY DILATATION; ARTICLE; BIOASSAY; BRACHIAL ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DRUG MECHANISM; FOREARM BLOOD FLOW; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SHEAR STRESS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE; VASOMOTOR REFLEX;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BIOLOGICAL MARKERS; BLOOD FLOW VELOCITY; BRACHIAL ARTERY; CORONARY DISEASE; ECHOCARDIOGRAPHY, DOPPLER, PULSED; ELECTROCARDIOGRAPHY; ENDOTHELIUM, VASCULAR; FIBRINOLYSIS; HUMANS; ISOQUINOLINES; MALE; MUSCLE, SMOOTH, VASCULAR; NITRIC OXIDE; OXIDATIVE STRESS; PLASMINOGEN ACTIVATOR INHIBITOR 1; TETRAHYDROISOQUINOLINES; TREATMENT OUTCOME; VASODILATION;

EID: 0006567214     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(98)00862-5     Document Type: Article

References (28)

1. Ludmer P.L., Selwyn A.P., Shook T.L., Wayne R.R., Mudge G.H., Alexander R.W., Ganz P. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 315:1986;1046-1051.
2. Yasue H., Matsuyama K., Okumura K., Morikami Y., Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Possible role of early coronary atherosclerosis. Circulation. 81:1990;482-490.
3. Vita J.A., Treasure C.B., Nabel E.G., McLenachan J.M., Fish R.D., Yeung A.C., Vekshtein V.I., Selwyn A.P., Ganz P. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 81:1990;491-497.
4. Zeiher A.M., Drexler H., Wollschlager H., Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with early stages of atherosclerosis. Circulation. 83:1991;391-401.
5. Quyyumi A.A., Daka N., Andrews N.P., Husain S., Arora S., Gilligan D.M., Panza J.A., Cannon R.O. III. Nitric oxide activity in the human coronary circulation. Impact of risk factors for atherosclerosis. J Clin Invest. 95:1995;1747-1755.
6. Panza J.A., Quyyumi A.A., Brush J.E. Jr, Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 323:1990;22-27.
7. Casino P.R., Kilcoyne C.M., Quyyumi A.A., Hoeg J.M., Panza J.A. Role of nitric oxide in the endothelium-dependent vasodilation in hypercholesterolemic patients. Circulation. 88:1993;2541-2547.
8. Celermajer D.S., Sorensen K.E., Georgakopoulos D., Bull C., Thomas O., Robinson J., Deanfield J.E. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults. Circulation. 88:1993;2149-2155.
9. Celermajer D.S., Sorensen K.E., Bull C., Robinson J., Deanfield J.E. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction. J Am Coll Cardiol. 24:1994;1468-1474.
10. Mancini G.B.J., Henry G.C., Macaya C., O'Neill B.J., Pucillo A.L., Carere R.G., Wargovich T.J., Mudra H., Luscher T.F., Klibaner M.I., Haber H.E., Uprichard A.C.G., Pepine C.J., Pitt B. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease the TREND study (Trial on Reversing Endothelial Dysfunction) . Circulation. 94:1996;258-265.
11. Effects of quinapril on coronary blood flow in coronary artery disease patients with endothelial dysfunction. Am J Cardiol. 80:1997;1596-1597.
12. Mombouli J.V., Vanhoutte P.M. Kinins and endothelial-dependent relaxation to convertin-enzyme inhibitors in perfused canine arteries. J Cardiovasc Pharmacol. 18:1991;926-927.
13. G monomethyl-L-arginine attenuates the vasodilator action of bradykinin in the human forearm. J Clin Pharmacol. 38:1994;311-315.
14. Griendling K.K., Ollerenshaw J.D., Minieri C.A., Alexander R.W. Angiotensin II stimulates NADH and NADPH activity in cultured vascular smooth muscle cells. Circ Res. 74:1994;1141-1148.
15. Pagano P.J., Ito Y., Tornheim K., Gallop P.M., Tauber A.I., Cohen R.A. An NADPH oxidase superoxide-generating system in the rabbit aorta. Am J Physiol. 268:1995;H2274-H2280.
16. Mohazzab K.M., Kaminski P.M., Wolin M.S. NADH oxidoreductase is a major source of superoxide anion in bovine coronary artery endothelium. Am J Physiol. 266:1994;H2568-H2572.
17. Chin J.H., Azhar S., Hoffman B.B. Inactivation of endothelial derived relaxing factor by oxidized lipoproteins. J Clin Invest. 89:1992;10-18.
18. DeCaterina R., Libby P., Peng H.-B., Thannickal V.J., Rajarashisth T.B., Gimbrone M.A., Shin W.S., Liao J.K. Nitric oxide decreases cytokine-induced activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest. 96:1995;60-68.
19. Vaughan D.E., Lazos S.A., Tong K. Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin angiotensin system and thrombosis. J Clin Invest. 95:1995;995-1001.
20. White J.W. Jr. Relative significance of dietary sources of nitrate and nitrite. J Agric Food Chem. 23:1975;886-891.
21. Celermajer D.S., Sorensen K.E., Gooch V.M., Spiegelhalter D.J., Miller O.I., Sullivan I.D., Lloyd J.K., Deanfield J.E. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 340:1992;1111-1115.
22. Joannides R., Haefeli W.E., Linder L., Richard V., Bakkali E.H., Thuillez C., Luscher T.F. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation. 91:1995;1314-1319.
23. Wennmalm A., Benthin G., Edlund A., Jungersten L., Kieler-Jensen N., Lundin S., Westfelt U.N., Petersson A.S., Waagstein F. Metabolism and excretion of nitric oxide in humans. An experimental and clinical study. Circ Res. 73:1993;1121-1127.
24. Buga G.M., Griscavage J.M., Rogers N.E., Ignarro L.J. Negative feedback regulation of endothelial cell function by nitric oxide. Circ Res. 73:1993;808-812.
25. Buttery L.D., Springall D.R., Chester A.H., Evans T.J., Standfield E.N., Parums D.V., Yacoub M.H., Polak J.M. Inducible nitric oxide synthase is present within human atherosclerotic lesions and promotes the formation and activity of peroxynitrite. Lab Invest. 75:1996;77-85.
26. Hwang S.-J., Ballantyne C.M., Sharrett R., Smith L.C., Davis C.E., Gotto A.M. Jr, Boerwinkle E. Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. The Atherosclerosis Risk in Communities (ARIC) study. Circulation. 96:1997;4219-4225.
27. Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. Circulation. 96:1997;442-447.
28. Ridker P.M., Gaboury C.L., Conlin P.R., Seely E.W., Williams G.H., Vaughan D.E. Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function. Circulation. 87:1993;1969-1973.